Live feed
Filing
SC 13D
SC 13D0000905718-21-000606·Abingworth LLP
Schedule 13D ownership disclosure
RENEO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75974E103
Event date: 2021-04-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,858,226
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-21-000606
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- Apr 20, 2021
- Reporting period
- Apr 13, 2021
- Description
- Schedule 13D beneficial ownership